Author(s): Bhatia K., Nethra S., Gardiner S.
Abstract: Women with postmenopausal bleeding are triaged as 2 week rule into our One-stop diagnostic hysteroscopy clinics. Up to 20% may have polypiod endometrial lesions, some of which may well be malignant or pre-malignant. Conventionally within NHS settings, majority of these cases are admitted as Day Case for resection of polyps / lesions under general anaesthetic. A significant proportion of these postmenopausal women have medical co-morbidities posing risk for general anaesthesia and require intensive pre-operative assessment before they can have this relatively minor operation. Apart from patient inconvenience, unnecessary utilisation of theatre slots and resource implications for preoperative / anaesthetic assessments, it also adds to the delay in 2 week rule diagnostic and treatment pathway. As a result the UK government has now introduced Best Practise tariffs for See & Treat therapeutic hysteroscopy procedures in clinic setting. TRUCLEAR hysteroscopic morcellator is now recognised to be the most effective outpatient modality for removing endometrial lesions under direct vision with unique tissue retrieval system. To ensure a See &Treat service that is cost effective and clinically effective, we submitted a business plan for the purchase of TRUCLEAR and obtained approval from the Commissioners for appropriate Best Practise tariff. We would like to share our experience in the ups and downs of starting a new Quality Improvement service under the current NHS financial situation and present our data on the new service which started in December 2014.
Publication Type: Journal: Conference Abstract